These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35843834)

  • 21. Laboratory analysis of two Delta SARS-CoV-2 variant outbreaks in the Port of Antwerp.
    Boogaerts HLF; Smits P; Hans G; Bouly L; Coeck E; Vandamme S; Jansens H; Goossens H; Matheeussen V
    Acta Clin Belg; 2022 Dec; 77(6):925-932. PubMed ID: 34851231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India.
    Yadav PD; Nyayanit DA; Majumdar T; Patil S; Kaur H; Gupta N; Shete AM; Pandit P; Kumar A; Aggarwal N; Narayan J; Vijay N; Kalawat U; Sugunan AP; Munivenkatappa A; Sharma T; Devi S; Majumdar T; Jaryal S; Bakshi R; Joshi Y; Sahay R; Shastri J; Singh M; Kumar M; Rawat V; Dutta S; Yadav S; Krishnasamy K; Raut S; Biswas D; Borkakoty B; Verma S; Rani S; Deval H; Patel D; Turuk J; Malhotra B; Fomda B; Nag V; Jain A; Bhargava A; Potdar V; Cherian S; Abraham P; Gopal A; Panda S; Bhargava B
    Viruses; 2021 May; 13(5):. PubMed ID: 34067745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic evolution of the SARS-CoV-2 Variants of Concern: COVID-19 pandemic waves in India.
    Bhardwaj P; Mishra SK; Behera SP; Zaman K; Kant R; Singh R
    EXCLI J; 2023; 22():451-465. PubMed ID: 37534220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-sectional genomic perspective of epidemic waves of SARS-CoV-2: A pan India study.
    Kumar S; Bansal K
    Virus Res; 2022 Jan; 308():198642. PubMed ID: 34822953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic sequencing detected the SARS-CoV-2 delta variant in wastewater a month prior to the first COVID-19 case in Ahmedabad (India).
    Joshi M; Kumar M; Srivastava V; Kumar D; Rathore DS; Pandit R; Graham DW; Joshi CG
    Environ Pollut; 2022 Oct; 310():119757. PubMed ID: 35853573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroepidemiological and genomic investigation of SARS-CoV-2 spread in North East region of India.
    Wahengbam R; Bharali P; Manna P; Phukan T; Singh MG; Gogoi G; Tapadar YB; Singh AK; Konwar R; Chikkaputtaiah C; Velmurugan N; Nagamani S; Mahanta HJ; Sarma H; Sahu RK; Dutta P; Wann SB; Kalita J; Sastry GN
    Indian J Med Microbiol; 2023; 43():58-65. PubMed ID: 36371334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and Whole Genome Sequencing of SARS-CoV-2 Circulating During the First Three Waves of the COVID-19 Pandemic in Libreville and the Haut-Ogooué Province in Gabon.
    Lekana-Douki SE; N'dilimabaka N; Levasseur A; Colson P; Andeko JC; Zong Minko O; Banga Mve-Ella O; Fournier PE; Devaux C; Ondo BM; Akombi FL; Yacka Mouele Bolo L; Ngonga Dikongo AM; Diané A; Mabika Mabika A; Mathouet JF; Dzembo C; Atiga NC; Mouity Matoumba A; Ndjangangoye NK; Bréchard L; Bedotto-Buffet M; Mangombi Pambou JB; Kandet Yattara M; Mbongo Nkama EA; Mintsa Ndong A; Adegnika AA; Raoult D; Fenollar F; Lekana-Douki JB
    Front Med (Lausanne); 2022; 9():877391. PubMed ID: 35655849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of novel Corona Virus (severe acute respiratory syndrome Coronavirus 2) and its uncertain future in the different regions of Punjab.
    Sidhu SK; Singh K; Tuli AK; Bigdelitabar S; Jairath M
    Indian J Public Health; 2022; 66(1):45-48. PubMed ID: 35381713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.
    Nygaard U; Holm M; Hartling UB; Glenthøj J; Schmidt LS; Nordly SB; Matthesen AT; von Linstow ML; Espenhain L
    Lancet Child Adolesc Health; 2022 Jul; 6(7):459-465. PubMed ID: 35526537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative analysis of the second and third wave of the Covid-19 pandemic: an experience from a tertiary care hospital in Western India.
    Swami A; Mohanty A; Jamwal A; Turbadkar D; Baveja S; Shastri J; Chitalia V
    J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37171852
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of symptoms along with depression, anxiety and stress levels of Sars-CoV-2 positive patients during the second wave in the city of Indore, Central India - a cross sectional study.
    Shah J; Srivastava R; Singh Hada D; Singh M; Jain D
    Przegl Epidemiol; 2022; 76(3):296-303. PubMed ID: 36520040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India.
    Yadav PD; Nyayanit DA; Gupta N; Shastri J; Sahay RR; Patil DY; M Shete A; Razdan A; Agrawal S; Kumar A; Majumdar T; Patil S; Sarkale P; Baradkar S; Dudhmal M; Kaur H; Aggarwal N
    J Med Virol; 2022 Jul; 94(7):3404-3409. PubMed ID: 35211985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.
    Taytard J; Prevost B; Schnuriger A; Aubertin G; Berdah L; Bitton L; Dupond-Athenor A; Thouvenin G; Nathan N; Corvol H
    Front Pediatr; 2022; 10():932170. PubMed ID: 35832582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.
    Desai D; Khan AR; Soneja M; Mittal A; Naik S; Kodan P; Mandal A; Maher GT; Kumar R; Agarwal A; Gowda NR; H V; Kumar P; Pandey S; Pandey RM; Kumar A; Ray A; Jorwal P; Nischal N; Choudhary A; Brijwal M; Madan K; Lodha R; Sinha S; Dar L; Wig N; Guleria R
    Lancet Infect Dis; 2022 Mar; 22(3):349-356. PubMed ID: 34826383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of Novel SARS-CoV-2 variants in India: second wave.
    Adiga R; Nayak V
    J Infect Dev Ctries; 2021 Nov; 15(11):1578-1583. PubMed ID: 34898481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification, propagation and molecular characterization of SARS-CoV-2 delta variant isolated from Egyptian COVID-19 patients.
    Alotaibi B; El-Masry TA; Seadawy MG; El-Harty BE; Saleh A; Gad AF; El-Hosseny MF; Mahran YF; El-Bouseary MM
    Infect Genet Evol; 2022 Jun; 100():105278. PubMed ID: 35367360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dynamic change of SARS-CoV-2 variants in Sierra Leone.
    Lin L; Zhang J; Rogers J; Campbell A; Zhao J; Harding D; Sahr F; Liu Y; Wurie I
    Infect Genet Evol; 2022 Mar; 98():105208. PubMed ID: 34999288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breakthrough infection with SARS-CoV-2 delta variant in old-age homes in a Southern District of Kerala, India.
    Chandran D; Sreekumar E; Prajitha KC; Sharahudeen A; Raveendran CL;
    Indian J Public Health; 2022 Nov; 66(Supplement):S36-S40. PubMed ID: 36412471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.